SCHEMBL4280331

SCHEMBL4280331

C=CC(CC(=O)O)CC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.43
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 2/20 0.41
CYP2D6 P10635 2/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
BLM P54132 1/20 0.41
SLC6A3 Q01959 1/20 0.41
MEN1 O00255 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
GABRR1 P24046 2/20 0.36
LMNA P02545 2/20 0.36
FOLH1 Q04609 1/20 0.33
MAPT P10636 2/20 0.32
ALOX15 P16050 2/20 0.32
ABCC4 O15439 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29951485 0.87
SCHEMBL28518615 0.87
SCHEMBL29955089 0.87
SCHEMBL614027 0.85
SCHEMBL29237760 0.83 SLC6A2 (0.39) SLC22A6TDP1TSHRCYP2D6SLC6A2
SCHEMBL7702223 0.83 SLC6A2 (0.54) TSHRCYP2D6SLC6A2SLC6A4BLM
SCHEMBL3484857 0.82 SLC6A2 (0.31) SLC22A6TDP1TSHRCYP2D6SLC6A2
SCHEMBL12447855 0.81 CACNA2D1 (0.45) SLC22A6TDP1TSHRCYP2D6SLC6A2
SCHEMBL8006389 0.81 GPR84 (0.39) SLC22A6TDP1TSHRCYP2D6SLC6A2
SCHEMBL11136259 0.78 CYP2D6 (0.48) SLC22A6TDP1TSHRCYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3157998-B1 MOISTURE-CURABLE POLYMERIC COMPOSITIONS HAVING HALOGENATED POLYMERS AND METAL MERCAPTIDES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-07-25 EP claimed
EP-2334718-B1 POLY VINYL CHLORIDE FOAM PROMOTERS PMC ORGANOMETALLIX INC (US) 2016-02-17 EP claimed
EP-1263869-B1 HALOGEN CONTAINING POLYMER COMPOUNDS CONTAINING MODIFIED ZEOLITE STABILIZERS NOVEON IP HOLDINGS CORP (US) 2006-03-29 EP claimed
EP-1115787-B1 HALOGEN CONTAINING POLYMER COMPOUNDS CONTAINING MODIFIED ZEOLITE STABILIZERS NOVEON IP HOLDINGS CORP (US) 2004-11-24 EP claimed
US-20160319079-A1 CROSS-LINKABLE SILICONE COMPOSITION WACKER CHEMIE AG (DE) 2016-11-03 US disclosed
EP-3083856-A1 CROSS-LINKABLE SILICONE COMPOSITION Wacker Chemie AG (DE) 2016-10-26 EP disclosed
CN-105940068-A Crosslinkable silicone composition 瓦克化学股份公司 2016-09-14 CN disclosed
CN-104230664-B Process for producing allyl alcohol DAIREN CHEMICAL CORP. (CN) 2016-03-02 CN disclosed
WO-2015090374-A1 CROSS-LINKABLE SILICONE COMPOSITION WACKER CHEMIE AG (DE) 2015-06-25 WO disclosed
US-20090294362-A1 STATIONARY PHASE FOR HYDROPHILIC INTERACTION CHROMATOGRAPHY MERCK PATENT GMBH (DE) 2009-12-03 US disclosed
EP-0873185-B1 A POLYMERIZATION PROCESS AND APPARATUS FREEMAN CLARENCE S (US) 2003-05-21 EP disclosed
US-20020193546-A1 Polymerization process, apparatus mid polymer WATERGUARD TELECOMMUNICATIONS TECHNOLOGIES, INC. A TEXAS CORPORATION (US) 2002-12-19 US disclosed
US-20010053845-A1 Anthracycline analogues bearing latent alkylating substituents BOARD OF REGENTS 2001-12-20 US disclosed
US-6291605-B1 PREPARING A MIXTURE OF A MONOMER, A CROSSLINKER AND AN INITIATOR IN WATER; HEATING REACTION CHAMBER; CONTROLLING PRESSURE; SPRAYING MIXTURE; ALLOWING DROPLETS TO FALL THROUGH HEATED CHAMBER TO POLYMERIZE AND CROSSLINK FORMING DRY WATERGUARD TELECOMMUNICATIONS TECHNOLOGIES, INC. 2001-09-18 US disclosed
US-6284737-B1 ANTICARCER AGENTS PRO-NEURON, INC. 2001-09-04 US disclosed
EP-0873185-A1 A POLYMERIZATION PROCESS, APPARATUS AND POLYMER Freeman, Clarence S. (US) 1998-10-28 EP disclosed
WO-1996040427-A1 A POLYMERIZATION PROCESS, APPARATUS AND POLYMER FREEMAN CLARENCE S (US) 1996-12-19 WO disclosed
EP-0555358-B1 ANTHRACYCLINE ANALOGUES BEARING LATENT ALKYLATING SUBSTITUENTS UNIV TEXAS (US) 1994-08-10 EP disclosed
US-5196522-A Antitumor BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-03-23 US disclosed
EP-0079501-B1 OPEN-CELL SHAPED ARTICLES MADE OF POLYVINYL ACETALS HOECHST AKTIENGESELLSCHAFT (DE) 1986-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010053845-A1 Anthracycline analogues bearing latent alkylating substituents BCR, MCL1, NCL SLC22A6 2499/4885TDP1 475/4885TSHR 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.